Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 37

1.

The T-cell fingerprint of MALT1 paracaspase revealed by selective inhibition.

Bardet M, Unterreiner A, Malinverni C, Lafossas F, Vedrine C, Boesch D, Kolb Y, Kaiser D, Glück A, Schneider MA, Katopodis A, Renatus M, Simic O, Schlapbach A, Quancard J, Régnier CH, Bold G, Pissot-Soldermann C, Carballido JM, Kovarik J, Calzascia T, Bornancin F.

Immunol Cell Biol. 2018 Jan;96(1):81-99. doi: 10.1111/imcb.1018. Epub 2017 Dec 21.

PMID:
29359407
2.

Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2.

Arenas-Ramirez N, Zou C, Popp S, Zingg D, Brannetti B, Wirth E, Calzascia T, Kovarik J, Sommer L, Zenke G, Woytschak J, Regnier CH, Katopodis A, Boyman O.

Sci Transl Med. 2016 Nov 30;8(367):367ra166.

PMID:
27903862
3.

Deficiency of MALT1 paracaspase activity results in unbalanced regulatory and effector T and B cell responses leading to multiorgan inflammation.

Bornancin F, Renner F, Touil R, Sic H, Kolb Y, Touil-Allaoui I, Rush JS, Smith PA, Bigaud M, Junker-Walker U, Burkhart C, Dawson J, Niwa S, Katopodis A, Nuesslein-Hildesheim B, Weckbecker G, Zenke G, Kinzel B, Traggiai E, Brenner D, Brüstle A, St Paul M, Zamurovic N, McCoy KD, Rolink A, Régnier CH, Mak TW, Ohashi PS, Patel DD, Calzascia T.

J Immunol. 2015 Apr 15;194(8):3723-34. doi: 10.4049/jimmunol.1402254. Epub 2015 Mar 11.

4.

Nuclear orphan receptor NR2F6 directly antagonizes NFAT and RORγt binding to the Il17a promoter.

Hermann-Kleiter N, Meisel M, Fresser F, Thuille N, Müller M, Roth L, Katopodis A, Baier G.

J Autoimmun. 2012 Dec;39(4):428-40. doi: 10.1016/j.jaut.2012.07.007. Epub 2012 Aug 24.

5.

Oxysterols direct immune cell migration via EBI2.

Hannedouche S, Zhang J, Yi T, Shen W, Nguyen D, Pereira JP, Guerini D, Baumgarten BU, Roggo S, Wen B, Knochenmuss R, Noël S, Gessier F, Kelly LM, Vanek M, Laurent S, Preuss I, Miault C, Christen I, Karuna R, Li W, Koo DI, Suply T, Schmedt C, Peters EC, Falchetto R, Katopodis A, Spanka C, Roy MO, Detheux M, Chen YA, Schultz PG, Cho CY, Seuwen K, Cyster JG, Sailer AW.

Nature. 2011 Jul 27;475(7357):524-7. doi: 10.1038/nature10280.

6.
7.

Differential promotion of hematopoietic chimerism and inhibition of alloreactive T cell proliferation by combinations of anti-CD40Ligand, anti-LFA-1, everolimus, and deoxyspergualin.

Metzler B, Gfeller P, Wieczorek G, Katopodis A.

Transpl Immunol. 2008 Nov;20(1-2):106-12. doi: 10.1016/j.trim.2008.07.002. Epub 2008 Jul 31.

PMID:
18675355
8.

Modulation of T cell homeostasis and alloreactivity under continuous FTY720 exposure.

Metzler B, Gfeller P, Wieczorek G, Li J, Nuesslein-Hildesheim B, Katopodis A, Mueller M, Brinkmann V.

Int Immunol. 2008 May;20(5):633-44. doi: 10.1093/intimm/dxn023. Epub 2008 Mar 14.

PMID:
18343890
9.

Anti-LFA-1 monotherapy prevents neointimal formation in a murine model of transplant intimal hyperplasia.

Soleimani B, Wieczorek G, Katopodis A, Zenke G, George AJ, Hornick PI, Weitz-Schmidt G.

J Heart Lung Transplant. 2007 Jul;26(7):724-31.

PMID:
17613404
10.

Smooth muscle cell proliferation but not neointimal formation is dependent on alloantibody in a murine model of intimal hyperplasia.

Soleimani B, Katopodis A, Wieczorek G, George AJ, Hornick PI, Heusser C.

Clin Exp Immunol. 2006 Dec;146(3):509-17.

11.

Non-covalent polyvalent ligands by self-assembly of small glycodendrimers: a novel concept for the inhibition of polyvalent carbohydrate-protein interactions in vitro and in vivo.

Thoma G, Streiff MB, Katopodis AG, Duthaler RO, Voelcker NH, Ehrhardt C, Masson C.

Chemistry. 2005 Dec 16;12(1):99-117.

PMID:
16231293
12.

The effect of soluble complement receptor type 1 on acute humoral xenograft rejection in hDAF-transgenic pig-to-primate life-supporting kidney xenografts.

Lam TT, Hausen B, Hook L, Lau M, Higgins J, Christians U, Jacobsen W, Baluom M, Duthaler R, Katopodis A, Chavez G, Cozzi E, Harrison R, Schuurman HJ, Borie D, Morris RE.

Xenotransplantation. 2005 Jan;12(1):20-9.

PMID:
15598270
14.

Hyperacute rejection of hDAF-transgenic pig organ xenografts in cynomolgus monkeys: influence of pre-existing anti-pig antibodies and prevention by the alpha GAL glycoconjugate GAS914.

Lam TT, Hausen B, Boeke-Purkis K, Paniagua R, Lau M, Hook L, Berry G, Higgins J, Duthaler RO, Katopodis AG, Robbins R, Reitz B, Borie D, Schuurman HJ, Morris RE.

Xenotransplantation. 2004 Nov;11(6):517-24.

PMID:
15479461
15.

Failure to deplete anti-Galalpha1-3Gal antibodies after pig-to-baboon organ xenotransplantation by immunoaffinity columns containing multiple Galalpha1-3Gal oligosaccharides.

Mañez R, Domenech N, Centeno A, Lopez-Pelaez E, Crespo F, Juffe A, Duthaler RO, Katopodis AG.

Xenotransplantation. 2004 Sep;11(5):408-15.

PMID:
15303977
16.

Reduction of anti-Galalpha1,3Gal antibodies by infusion of types 2 and 6 gal trisaccharides conjugated to poly-L-lysine.

Kuwaki K, Knosalla C, Moran K, Alt A, Katopodis AG, Duthaler RO, Schuurman HJ, Awwad M, Cooper DK.

Xenotransplantation. 2004 Mar;11(2):210-5.

PMID:
14962283
17.

Depletion of anti-Gal antibodies by the intravenous infusion of Gal type 2 and 6 glycoconjugates in baboons.

Teranishi K, Alwayn IP, Bühler L, Gollackner B, Knosalla C, Huck J, Duthaler R, Katopodis A, Sachs DH, Schuurman HJ, Awwad M, Cooper DK.

Xenotransplantation. 2003 Jul;10(4):357-67.

PMID:
12795685
18.

Improvement in human decay accelerating factor transgenic porcine kidney xenograft rejection with intravenous administration of gas914, a polymeric form of alphaGAL.

Zhong R, Luo Y, Yang H, Garcia B, Ghanekar A, Luke P, Chakrabarti S, Lajoie G, Phillips MJ, Katopodis AG, Duthaler RO, Cattral M, Wall W, Jevnikar A, Bailey M, Levy GA, Grant DR.

Transplantation. 2003 Jan 15;75(1):10-9.

PMID:
12544864
19.

Removal of anti-Galalpha1,3Gal xenoantibodies with an injectable polymer.

Katopodis AG, Warner RG, Duthaler RO, Streiff MB, Bruelisauer A, Kretz O, Dorobek B, Persohn E, Andres H, Schweitzer A, Thoma G, Kinzy W, Quesniaux VF, Cozzi E, Davies HF, Mañez R, White D.

J Clin Invest. 2002 Dec;110(12):1869-77.

20.

Depletion of natural anti-pig antibodies by the continuous infusion of oligosaccharides in a pig-to-baboon model.

Teranishi K, Alwayn IP, Bühler L, Gollackner B, Knosalla C, Correa L, Down JD, White-Scharf ME, Sachs DH, Duthaler R, Katopodis A, Awwad M, Cooper DK.

Transplant Proc. 2002 Nov;34(7):2757-8. No abstract available.

PMID:
12431597
21.

Novel glycodendrimers self-assemble to nanoparticles which function as polyvalent ligands in vitro and in vivo.

Thoma G, Katopodis AG, Voelcker N, Duthaler RO, Streiff MB.

Angew Chem Int Ed Engl. 2002 Sep 2;41(17):3195-8. No abstract available.

PMID:
12207387
22.

The alpha-Gal analog GAS914 ameliorates delayed rejection of hDAF transgenic pig-to-baboon renal xenografts.

Ghanekar A, Luo Y, Yang H, Garcia B, Luke P, Chakrabarti S, Lajoie G, Phillips MJ, Katopodis A, Cattral MS, Wall W, Jevnikar A, Bailey M, Levy GA, Grant DR, Zhong R.

Transplant Proc. 2001 Nov-Dec;33(7-8):3853-4. No abstract available.

PMID:
11750640
23.

Removal of bowel aerobic gram-negative bacteria is more effective than immunosuppression with cyclophosphamide and steroids to decrease natural alpha-galactosyl IgG antibodies.

Mañez R, Blanco FJ, Díaz I, Centeno A, Lopez-Pelaez E, Hermida M, Davies HF, Katopodis A.

Xenotransplantation. 2001 Feb;8(1):15-23.

PMID:
11208187
24.

P-selectin glycoprotein ligand-1 supports rolling on E- and P-selectin in vivo.

Norman KE, Katopodis AG, Thoma G, Kolbinger F, Hicks AE, Cotter MJ, Pockley AG, Hellewell PG.

Blood. 2000 Nov 15;96(10):3585-91.

25.

Augmented anti-alphaGalactosyl antibodies in adult baboons in the setting of intestinal parasitic infections are not associated with higher titers of anti-pig hemolytic antibody.

Lopez E, Centeno A, Crespo F, Juffe A, Filgueira P, Veira P, Warner R, Katopodis A, Manez R.

Transplant Proc. 2000 Aug;32(5):890-1. No abstract available.

PMID:
10936261
26.

Neutralization of anti-alphaGalactosyl antibodies without immunosuppression prevents hyperacute rejection but not acute vascular rejection of pig organs transplanted into baboons.

Manez R, Crespo F, Gonzalez E, Centeno A, Juffe A, Arnal F, Cozzi E, White DJ, Duthaler R, Kinzy W, Oehrlein R, Katopodis A.

Transplant Proc. 2000 Aug;32(5):888-9. No abstract available.

PMID:
10936260
27.

Sustained decrease of serum anti-galactose alpha 1-3-galactose antibodies in baboons by removing aerobic gram-negative bacteria from the bowel.

Manez R, Diaz I, Centeno A, Gonzalez E, Hermida M, Blanco F, Davies HF, Katopodis A.

Transplant Proc. 1999 Feb-Mar;31(1-2):947-8. No abstract available.

PMID:
10083419
28.

Force-mediated kinetics of single P-selectin/ligand complexes observed by atomic force microscopy.

Fritz J, Katopodis AG, Kolbinger F, Anselmetti D.

Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12283-8.

29.

Trafficking and localization studies of recombinant alpha1, 3-fucosyltransferase VI stably expressed in CHO cells.

Borsig L, Katopodis AG, Bowen BR, Berger EG.

Glycobiology. 1998 Mar;8(3):259-68.

PMID:
9451035
30.
31.

The carbohydrate-recognition domain of E-selectin is sufficient for ligand binding under both static and flow conditions.

Kolbinger F, Patton JT, Geisenhoff G, Aenis A, Li X, Katopodis AG.

Biochemistry. 1996 May 21;35(20):6385-92.

PMID:
8639584
32.

Kinetic analyses of peptidylglycine alpha-amidating monooxygenase from pancreatic islets.

Noe BD, Katopodis AG, May SW.

Gen Comp Endocrinol. 1991 Aug;83(2):183-92.

PMID:
1916206
33.
35.

Novel substrates and inhibitors of peptidylglycine alpha-amidating monooxygenase.

Katopodis AG, May SW.

Biochemistry. 1990 May 15;29(19):4541-8.

PMID:
2372538
36.

Hydrocarbon monooxygenase system of Pseudomonas oleovorans.

May SW, Katopodis AG.

Methods Enzymol. 1990;188:3-9. No abstract available.

PMID:
2280708
37.

Supplemental Content

Loading ...
Support Center